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Abstract 
 
The mechanism of action of tricyclic antidepressant (TCAs) is not fully understood.  The 
effect of the TCA imipramine on the haemolysis of erythrocytes was investigated, 
focussing on dosage and incubation time.  The method used a drug free red blood cell 
(RBC) haemolysis assay (Watts & Handy, 2007) comparing experimental drug 
concentrations ranging from 0.0904 mg/ml – 90.4 mg/ml.  Incubation time effects were 
also investigated, and haemolysis increased with decreasing osmolarity.  Compared 
with the control the percentage haemolysis increased significantly with higher 
concentrations of imipramine, but was reduced by 0.0904 mg/ml imipramine.  
Haemolysis also increased with longer incubation time in both experimental and drug-
free trials.  Findings show that imipramine has a haemolytic effect on RBCs that is both 
incubation time and concentration dependant.  Imipramine has a stabilising effect on 
RBCs at 0.0904 mg/ml around critical micelle concentration which could involve 
surface-drug-action and can be explained by Kesting’s liquid membrane hypothesis. 
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1.  Introduction 
 
1.1. Imipramine mechanism 
It is widely known that tricyclic antidepressants (TCA) are used to treat various 
psychological disorders; depression (Birkenhager, 2008), anxiety disorder (Stahl, 1998), 
eating disorders (Becker et al., 1999), and even chronic pain (McQuay et al., 1996).  
Imipramine, a classic TCA, is prescribed widely for treatment.  Therapeutic effects are 
seen after 2-4 weeks of chronic treatment with imipramine, the antidepressant 
influencing monoamine transmission in the brain affecting serotonergic, dopaminergic, 
and noradrenergic reuptake. Various aspects of the effects of TCAs and the wide 
spectrum of side effects are well documented but the mechanism of action is not fully 
understood.  There are non-dopaminergic effects in non-target tissues including 
changes in neurotransmission, ion exchanges and fluxes, cytokine release, and 
influences on fluid membranes.  This investigation looks at the effects of imipramine on 
haemolysis and attempt to establish a relationship between the observed findings and 
the mechanism of drug action. 
Liquid membranes form as a result of ampiphillic molecules.  Imipramine is a tricyclic 
amine with the hydrophilic and hydrophobic regions of a surface active drug.  Surface 
active drugs form a barrier at the site of action preventing transport of other lipid 
permeable substances and solutes (Nagappa et al., 2003). The ‘liquid membrane 
hypothesis of drug action (Srivastava et al., 1981; Nagappa et al., 2003), a recently 
proposed theory, provides a new principle to explain the mechanism of TCA. 
The ampiphillic structure, in an aqueous medium, forms a liquid membrane at surface-
membrane interface by a surfactant layer lowering the interfacial tension between the 
two liquids (Nagappa et al, 2003).  So imipramine molecules form a liquid membrane 
over the phospholipid bilayer of cells by surface adsorption (Fisar et al., 2004).  
Kesting’s liquid membrane hypothesis (Kesting et al., 1968) states that when the 
concentration of a surface active drug increases, the interface becomes covered with 
surfactant molecules forming the liquid membrane, when the membrane is complete it is 
said to be at ‘critical micelle concentration’ (CMC).  Formation of liquid membranes may 
influence movement of permeants through the surfactant layer thus affecting the 
mechanism of surface active drugs like imipramine; Nagappa et al (2003) demonstrated 
imipramine reducing permeability of biogenic amines such as dopamine, 5-HT, and 
norepinephrine, it also reduced permeability to cations when the concentration of 
imipramine was higher than its CMC.  Research of organic molecules in unstirred layer 
theory (Pohl et al., 1998) showed that transport of permeants can be reduced by 
surface adsorption dependant on size of the membrane formed and the solute diffusion 
coefficient.  This supports the hypothesis that their surface active properties affect the 
mechanism; the high concentration of drug allows for multiple layers of liquid membrane 
to form significantly reducing the movement of these permeants, if the monoamines are 
prevented from entering storage vesicles in the neuron their concentration increases in 
the synaptic cleft.  Applying this to the imipramine in vivo mechanism demonstrates that 
liquid membrane formation at neurons reduces the re-uptake of monoamines enhancing 
the antidepressant effect.  Similarly the liquid membrane theory can explain the 
imipramine side effect of postural hypotension.  Liquid membrane formation around 
muscle cells decreases calcium cation movement into the muscles, this reduces the 
effect of calcium in muscles, that of excitation and contraction resulting in increased 
blood pressure; hence the surface activity of imipramine contributes to the lowering of 
blood pressure (Nagappa et al. 2003).  The evidence of imipramine affecting cation 
movement indicates that it can significantly disrupt the regulatory volume control 
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mechanisms of cells as Na+ and K+ play an important role in the electrophysical 
properties of the cell membrane (Nagappa et al. 2003).  If the drug was at CMC or 
higher the regulatory volume control mechanisms may be compromised.  
Nagappa et al. (2003) studied the inhibitory effect on permeant movement by the 
formation of liquid membranes, using imipramine at a higher concentration than CMC; 2 
x 10-4 M.  It would be interesting to investigate the effects of partial liquid membrane 
formation when the drug is lower than its CMC, as it may affect permeants at less 
significant level, or have no effect at all.  TCAs also show an effect on cell signalling and 
cell volume control (Nagappa, 2003; Yasuhara et al., 1985).  Imipramine mechanism 
influences ion exchangers at the membrane and impinge on cell regulatory volume 
control.  It is important to understand the mechanisms involved in cell volume control as 
the action of imipramine affects this directly and so can influence the lysis of 
erythrocytes. 
 
1.2. Cell volume control 
Drug-induced haemolysis of RBCs can arise from immune and non-immune responses.  
This study focuses on non-immune related imipramine-induced haemolysis.  This non-
immune haemolysis may occur by disruption of CVC mechanisms.  The membrane of 
erythrocytes is an asymmetrically arranged phospholipid bilayer with unesterified 
cholesterol dispersed between the phospholipid molecules.  The level of cholesterol 
amongst the phospholipids affects the fluidity of the membrane.  Rigidity is influenced 
by the presence of membrane proteins within the lipid bilayer, there are three functional 
sets; catalytic, structural and receptor (Ballas & Krasnow, 1980).  Fundamental in CVC 
are structural proteins, spectrin and actin, providing the membrane with its viscoelastic 
properties (Ballas & Krasnow, 1980), allowing the cell to come under moderate stress 
and stretching to accommodate.  Osmoregulation is a key process in all animal cells 
(Okada et al., 2001); to survive, cells must avoid excessive alterations in cell volume in 
order to prevent damage to the membranes and integral structure of the cell (Lang et 
al., 1998).  Animal cells lack cell walls (Campbell & Reece, 2002) so if there is a 
continuous net uptake of water the cells swell and burst.  Water permeation occurs via 
diffusion through the lipid bilayer and via aquaporins that are strictly for water 
permeation and not ions.  The human cell contains many organelles and internal 
structures, even erythrocytes with a simple internal structure and few organelles contain 
a multitude of internal ions, transporter proteins, and many other membrane proteins 
(Ballas & Krasnow, 1980).  The erythrocyte cell membrane is semipermeable so all the 
internal substance of the cell can create osmotic pressure to draw water into the cell in 
a hypoosmotic environment.  The cell volume is controlled by changes in environmental 
ion concentration.  The response to changes in the surrounding medium must be 
controlled as the membrane has no resistance to bursting once the environment has a 
lower osmotic pressure than the physiological level.  Even if the extracellular 
environment remains stable the volume constancy must still be monitored by the cell as 
osmotically active molecules such as ions and other metabolites are constantly 
transported and changed by metabolic action (Lang et al., 1998).  Therefore actions of 
regulatory cell volume mechanisms are sustained constantly; the mechanisms involve 
cell membrane ion transport, management of the accumulation level of osmolytes and 
metabolites and the disposal of these in excess (Lang et al., 1998). 
The osmotic pressures of the cell are affected by Na+, K+, and Ca2+ ions having different 
concentrations inside and outside the cell.  This results in a membrane potential due to 
electropotential difference across the membrane.  The Na+/K+/Cl2
- pump-leak model 
demonstrates how the ions are both actively transported and move passively in CVC. 
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This maintains the intercellular and extracellular electrically neutral charges; so if the 
external environment has a higher osmolarity than the internal environment the pump 
adjusts for this, the osmolarity of human blood is approximately 300mosm/L (Campbell 
& Reece, 2002).  If anything disturbs the pump or inhibits its action the cell can no 
longer control the membrane potential and the cell lyses.  McCarty & O’Niel (1992) 
states that Ca2+ may play a central role in regulatory volume decrease mechanisms in 
most cells controlling hypotonic cell volume regulation.  Although further research is 
needed to determine the exact dependency of cell CVC on calcium ions, their initial 
studies indicated a possible direct control of K+: Cl- channels by calcium ions modulating 
K-Cl movement and so regulatory volume decrease.  Although Ca2+ does appear to 
have an effect on ion channels a phosphorylation step may be involved (Kracke & 
Dunham, 1990) and further biochemical action; CVC mechanisms are highly complex 
and are unlikely to be controlled solely by inner plasma membrane events, the signalling 
cascades are likely to involve biochemical pathways throughout the cell (McCarty & 
O’Niel, 1992).  Studies have countered these results and shown the lack of calcium ion 
dependency of CVC and the importance of cyclicAMP in the regulation of this system 
(Borgese et al., 1987).  However calcium ions do play a role in the regulation of 
erythrocyte cell volume; The Ca2+/Mg2+/ATPase enzyme is responsible for transport of 
calcium ions across biological membranes (Heguilen et al., 2008). The Ca2+ pump in 
red blood cells (Fig. 1) acts as a Ca2+H+ antiporter (Niggli et al., 1982) an electrogenic 
pump exchanging one calcium ion for a proton (Romero & Ortiz, 1988) so affecting the 
electrochemical arrangement at the membrane.  Similarly cellular Ca2+ and Mg2+ levels 
in erythrocytes influence the Na+/K+ pump fluxes so can have a substantial effect on cell 
volume regulation (Fujise & Lauf, 1988).  Two regulatory processes result in a dynamic 
equilibrium, regulatory volume increase (RVI) response via cyclicAMP regulated Na+ 
influx and regulatory volume decrease (RVD) response by passive Cl2
- dependent K+ 
efflux (Borgese et al., 1987). 
 
 
 
Fig. 1.  Ca
2+
H
+
 antiporter.  Schematic representation of Ca
2+
H
+
 antiporter 
anion fluxes in red blood cell. (Adapted: Niggli et al., 1982) 
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RVI and RVD mechanisms are thought to be signalled by intracellular events triggering 
the membrane proteins and transport systems and resulting in second messenger 
cascades.  The mechanisms result in adjusted intracellular ion composition and 
consequently altered cell membrane potential.  These regulatory systems are involved 
in osmoregulation, but can also affect epithelial transport and hormone release, and 
impaired RVI and RVD can play a role in pathophysiological apoptosis and necrotic cell 
death (Lang et al., 1998). 
 
1.3. Aims and objectives 
Research has reported that imipramine increases haemolysis of erythrocytes 
(Ahyayauch et al. 2004; Dutta et al. 2007) the aim of this study was to support or refute 
these findings based on new data.  The objectives of the experiment were 1) elaborate 
on the possible mechanisms of CVC, 2) investigate the influence of imipramine on these 
mechanisms, 3) determine if imipramine has a concentration-dependant haemolytic 
effect on RBCs, and 4) investigate the effect of prolonged exposure to the drug.  The 
null hypothesis is that imipramine HCL has no effect on erythrocyte haemolysis.  The 
alternative hypothesis is that imipramine HCL will have an effect on erythrocyte 
haemolysis. 
 
 
2.  Materials and methods 
 
2.1. Stock solutions 
 
2.1.1. Phosphate buffered saline 
1 buffer tablet (PBS, Dulbecco ‘A’ Tablet, Oxoid Ltd. Basingstoke, Hampshire, UK) was 
dissolved in 100 ml distilled water using an agitator to ensure all the powder was 
dissolved.  This produced 100 % PBS solution with a concentration of approximately 
140 mM NaCl at pH 7.4.  Using the 100 % PBS stock solution a series dilution was 
carried out (Table 1) to produce a NaCl concentration range of approximately 0 mM-140 
mM. 
 
PBS Dilution 
Proportion of PBS 
Stock (ml) 
Proportion of 
Distilled water (ml) 
NaCl concentration (mM) 
0 % 0 100 0 
10 % 10 90 14 
20 % 20 80 28 
30 % 30 70 42 
40 % 40 60 56 
50 % 50 50 70 
60 % 60 40 84 
70 % 70 30 98 
80 % 80 20 112 
90 % 90 10 126 
100 % 100 0 140 
 
Table 1. Series dilution proportions 
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2.1.2. Imipramine stock solution 
Imipramine HCL (C19H24N2 HCl MW 316.87) was obtained from Sigma-Aldrich (Poole, 
Dorset, UK) and a stock solution prepared.  Blood is denser than water so any 
concentration of drug to be made up with water must be adjusted for this density 
difference.  Calculations for the stock solution were carried out as follows, the 
imipramine HCL LD50 [Rat] was used as the starting concentration for the calculations:  
Imipramine HCL LD50 [Rat] = 305 mg/Kg.  The average human is 80 Kg and has 
approximately 7 pints of blood.  So of 80 Kg 7 % is blood; 80/100 x 7 = 5.6 Kg of blood.  
With a blood density of 1.06 g/cm3 and a blood-water ratio of 1.06:1.00 the volume of 
blood can be calculated.  5.6 Kg x 1.06 = 5.936 L.  So the LD50 of imipramine is 305 
mg in 80 Kg = 24.4 g in 5.936 L of blood.  The drug will be made up in 1.1 ml volume in 
total so 24.4 x 1.1/5936 = 4.52 mg/1.1 ml.  The volume of drug used in each trial is 50 µl 
so 4.25 x 20 = 90.4 mg/ml.  To make up a 10 ml stock solution at this LD50 
concentration 90.4 x 10 = 904.0 mg/10 ml. 
904.4 mg of imipramine HCL was measured out accurately using a closed weighing 
balance.  In a volumetric flask the weighed imipramine was made up to 10 ml with 
distilled water and shaken until all the powder was dissolved.  This provided the stock 
solution at 90.4 mg/ml imipramine HCL.  Further dilutions were made up with a dilution 
factor of 10 to provide a range of weaker solutions down to 0.0904 mg/ml. 
 
2.2. Cell preparation 
Horse erythrocytes were obtained from Oxoid Ltd (Basingstoke, Hampshire, UK).  The 
cells were supplied in citrate buffer from a live donor and were defibrinated to prevent 
clotting.  By obtaining the sample from a living donor ensured cells were in good 
condition to give clear and valid results.  The cells were washed and resuspended in 
physiological saline; the blood was kept on ice before and during procedure.  Using 10 
ml Fallon tubes the required amount of blood to be washed was placed into a Denley 
B5400 Benchtop Centrifuge.  The blood sample was centrifuged at 2000 rpm for 5 min.  
The tubes were removed from the centrifuge without disturbing the supernatant.  The 
supernatant was pipetted off and discarded.  Phosphate Buffered Saline (PBS) was 
added to maintain the volume of blood in the tube.  The PBS had been stored on ice to 
prevent heat shocking the cells.  The sample was then resuspended by gently rolling 
the tube in the palm of the hand to prevent damaging the cells by shaking.  This process 
was then repeated until the supernatant was clear and no more lysed cells were settling 
out of the solution.  A fresh sample of the donated blood was washed for every 
laboratory session. 
 
2.3. Haemolysis assay 
In order to draw conclusions from both time trial and dosage experiments with the drug, 
a control curve was produced.  The haemolysis assay was carried out with every new 
batch of blood and on consecutive laboratory sessions to obtain a standard curve for all 
experiments carried out in any one laboratory session.  For the dosage trials control 
1.05 ml of each of the serial dilutions of PBS were pipetted out into 11 correspondingly 
labelled Eppendorf tubes, giving a NaCl concentration range of approximately 140 mM 
– 0 mM.  50 µl of the washed blood sample was added to each tube and the tube 
sealed firmly, this step was carried out quickly to ensure the incubation time was even 
for each tube.  The tubes were inverted gently and allowed to incubate for 3 min then 
centrifuged (Microcentrifuge 5415D) at 13,000 rpm for 5 min.  Without disturbing the 
pellet the supernatant of each tube was pipetted into a 1 ml cuvette.  Using a 
Thermospectronic Heliose spectrophotometer the absorbance of each supernatant was 
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read at 540 nm and recorded in a table.  The spectrophotometer was blanked with 
physiological saline before reading the samples.  The process was repeated twice more 
to obtain triplicate results for means calculation.  Absorbance values were converted 
into percentage haemolysis using the mean of 100 % lysis controls.  This was used to 
calculate haemolysis for all the experiments using the relevant control data for the 
specific experiment, % Haemolysis = (absorbance of sample/average absorbance of 
100 % haemolysis control) x 100. 
For the time trial control 1.05 ml of 100 % PBS was pipetted into 18 Eppendorf tubes 
and 50 µl of blood added.  The tubes were inverted every 5 min to maintain the cells in 
suspension.  At 10 min intervals for a 60 min period three tubes were centrifuged and 
the absorbance reading taken as with the dosage haemolysis assay.  Converting 
absorbance into percentage haemolysis provided triplicate results of the amount of 
haemolysis at 10 minute intervals over an hour. 
 
2.4. Experiments 
2.4.1. Imipramine concentration trials 
The experiment was run as with the haemolysis assay above, but only 1 ml of each 
PBS solution was added to the Eppendorf tubes.  50 µl of the drug solution was added 
to each tube before adding the 50 µl of washed blood.  The tubes were incubated for 3 
minutes and centrifuged at 13,000 rpm for 5 min in a Microcentrifuge 5415D.  A range of 
drug concentrations was tested, each dose experiment repeated three times to 
calculate averages.  Corresponding triplicate haemolysis controls were carried out with 
50 µl of PBS in place of the drug as stated in haemolysis assay method. 
 
 
2.4.2. Incubation-time trials 
Only 100 % PBS solution was used in the time trials.  1 ml of 100 % PBS was pipetted 
into 18 Eppendorf tubes, 50 µl of the concentration of drug being tested and 50 µl of 
blood was pipetted into each tube.  The incubation times increased over an hour with 10 
min intervals, obtaining readings at 10, 20, 30, 40, 50, and 60 min.  The tubes were 
centrifuged and the readings taken of the supernatants as with the haemolysis assay.  
Three tubes were tested for each incubation time to provide triplicate results.  The tubes 
were all inverted gently every 5 min to keep the cells in suspension.  The time trial was 
run for all concentrations of drug to see the effect of time on the haemolysis of the cells 
at different dosages.  Corresponding triplicate haemolysis controls were carried out with 
50 µl of PBS in place of the drug as stated in haemolysis assay method. 
 
2.5. Statistics 
% Haemolysis was calculated for all data and expressed as a mean of the triplicate 
readings.  Data of imipramine concentration dependent haemolysis was analysed using 
a paired t-test to compare treatments and a one-way ANOVA to compare specific data 
points, time dependent haemolysis results were analysed using one-way ANOVA.  Time 
and dose effect were compared using a two-way ANOVA.  The program used was 
SPSS 16.0.  Differences were significant if p < 0.05. 
 
3. Results 
The haemolysis assay was as expected in trials with untreated cells; 100 % Haemolysis 
around 70-84 mM NaCl and below.  Variation was due to the variation in the blood 
samples; erythrocyte count, age of the blood in situ, and the washing procedure.  This 
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batch effect can influence all the results so a corresponding haemolysis assay control is 
given with each new batch of results. 
 
3.1. Imipramine concentration dependent haemolysis 
The dosage trials of imipramine HCL varied in effects; 90.04 mg/ml gave 100 % lysis at 
all NaCl concentrations with significantly greater lysis than the control in all readings (t-
test, P <0.05) (Fig. 3).  9.04 mg/ml and 0.904 mg/ml both caused greater lysis than the 
control, but were close to the results for the control.  0.0904 mg/ml showed unusual 
results; this lowest concentration appeared to cause less haemolysis than the control at 
lower [NaCl] when the cells were under more stress.  The control caused 100 % 
haemolysis at 14 mM NaCl whereas the 0.0904 mg/ml drug trial caused 96 % 
haemolysis (Fig. 2). This result was from a triplicate set of results and when the repeats 
were split the same lysis effect was seen with the drug causing 93 %, 98 %, and 96 % 
haemolysis respectively at 14 mM NaCl, all significantly different from the control (t-test, 
P = 0.003). 
 
This result diverges from the pattern of the other drug concentrations which all caused 
relatively greater lysis than the control, so a repeat series of triplicate tests were carried 
out (Fig. 3).  In repeat one the control caused 98 % haemolysis at 14 mM NaCl whereas 
the 0.0904 mg/ml drug trial caused 95 % haemolysis, significantly less lysis seen with 
the drug trial (t-test, P = 0.012) (Fig. 3A), when the triplicates were split again the same 
lysis effect was seen with the drug causing 94 %, 96 %, and 96 % haemolysis 
respectively at 14 mM NaCl.  A further repeat also showed 0.0904 mg/ml having a lower 
haemolytic effect; at 0 mM NaCl, the control gave 100 % lysis but the drug only caused 
 
 
Fig. 2.  Effect of lowest and highest imipramine concentration on haemolysis of RBCs 
in varied extracellular osmolarity.  Control drug-free dilution series (●), 90.4 mg/ml (○), 
0.0904 mg/ml (▼).  Cells were incubated for 3 min.  Data plots are means as a percentage of 
100 % lysis control, n = 3.   0.0904 mg/ml caused significantly less lysis compared to 
control at lower [NaCl] where the cells were under greater stress, 14 mM (t-test P <0.05. 
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82 % lysis (Fig. 3B).  The two repeats are not comparable as they were carried out 
during different lab sessions with different blood samples, the relationship in the result is 
clear.  In both repeats the drug caused less haemolysis than the respective control at 
low NaCl concentration when the cells were under greatest stress.  
 
 
Evidence of imipramine dosage affecting erythrocyte haemolysis is demonstrated by the 
fact that at 100 % PBS with 5 min incubation time the higher dosages of imipramine 
resulted in higher percentage lysis (Fig. 4).  The graph shows the concentration-
dependent effect of the drug up to 45.20 mg/ml.  At higher concentrations this effect 
 
 
 
 
 
 
Fig. 3.  Stabilising effect of 0.0904 mg/ml imipramine on RBC haemolysis in varied 
extracellular osmolarity. Drug-free control (●), 0.0904 mg/ml (○).  Cells were incubated 
for 3 min.  Data plots are means as a percentage of 100 % lysis control, n = 3.  3A 0.0904 
mg/ml vs. control P = 0.012 (t-test). 
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increases steeply, indicated by the slope of the line (Fig. 4).  After 5 min incubation 100 
% lysis is shown by 54.24 mg/ml and higher. 
 
3.2. Incubation-time dependent haemolysis 
The different concentrations of imipramine were investigated over a long incubation time 
to see the effect of different doses with extended incubation periods.  The control 
haemolysis assay for the time trials indicated that lysis increases over time without any 
drug present.  The control is used as a baseline haemolysis over time to compare with 
the haemolysis caused by increasing incubation time with drug.  An incubation time trial 
was not carried out for 90.4 mg/ml as it gave 100 % lysis after just 3 min incubation 
shown in the dosage experiment (Fig. 2).  The time trial carried out for 0.0904 mg/ml 
supported the results from the dosage experiment.  This low concentration of drug 
caused lower haemolysis than the control across the 60 min incubation time.  After 10 
minutes incubation the control caused 3 % lysis, whereas the 0.0904 mg/ml drug trial 
only caused 1 % lysis (Fig. 5). 
 
Dosage Effect at 100 % PBS
[Imipramine HCL] (mg/ml)
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Fig. 4.  Effect of varied imipramine concentration on RBC haemolysis at 100 % PBS.  
Rsq = 0.968 nonlinear regression. f= 184/(1+exp(-(x-x0)/10)).  Cells were incubated for 5 
min.  Data plots are mean  as a percentage of 100 % lysis control and SEM, n = 3. P <0.05 
(one-way ANOVA). 
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The time trials at higher concentrations (Fig. 6) showed corresponding results to the 
control; the higher concentrations of imipramine HCL showed a regular pattern of 
results with the percentage haemolysis increasing with increasing incubation time. The 
higher concentrations of drug reached 100 % haemolysis after a shorter incubation 
time, causing more lysis over a shorter time than the lower concentrations.  Above 
45.20 mg/ml the results were predictable with 100 % haemolysis being reached within 
the first 10 min of incubation, so the results for the time trials of 54.24 mg/ml, 63.28 
mg/ml, and 72.32 mg/ml imipramine looked much the same as 45.20 mg/ml (Fig. 6).  
The 0.904 mg/ml and 9.04 mg/ml concentrations of imipramine both caused <7 % lysis 
over the entire incubation time with haemolysis values close to those of the control 
which caused <5 % lysis over the entire incubation time.  These low imipramine 
concentrations of 0.904 mg/ml, 9.04 mg/ml and 18.08 mg/ml were not found to be 
significantly different to the control, the haemolysis for these concentrations were 
consistently similar to the haemolysis caused by the control over 60 min incubation.  
Both time and dosage effects were compared; dosage had a more significant effect on 
haemolysis that time (ANOVA, P = 0.008). 
 
 
 
 
 
 
0.0904mg/ml Time Trial
Incubation time (min)
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Fig. 5.  Effect of 0.0904 mg/ml imipramine over 60 min incubation  at 100 % PBS.  Drug-free 
control (●), 0.0904 mg/ml (○).  Cells were incubated for 5 min.  Data plots are means as a 
percentage of 100 % lysis control, n = 3.  0.0904 mg/ml imipramine caused significantly less lysis 
vs. control (P <0.05 ANOVA). 
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4. Discussion 
This study clearly demonstrated that imipramine effects lysis of horse erythrocytes.  
Both dosage and exposure influenced the rate and level of haemolysis, indicating that 
imipramine induced haemolysis is both concentration and time dependent.  Low 
concentrations of imipramine had a stabilising protective effect against haemolysis.  All 
experiments were in triplicate, ensuring valid results unaffected by human error and 
batch variables.  The haemolysis assay detailed in Watts & Handy (2007) supports the 
validity of the method used so valid conclusions may be drawn from the results. 
 
4.1. Clinical implications 
Clinical implications arise from the concentration and time-dependent haemolytic effects 
of imipramine.  Hospitalised depressed patients often have doses of imipramine 
increased up to 300 mg/day over a long period (Birkenhager et al., 2005).  In an 80 Kg 
human this equates to 0.05 mg/ml circulating dose, which according to the results is 
insufficient to cause haemolytic effects at normal physiological blood osmolarity; the 
lowest dose investigated, 0.0904 mg/ml, in fact showed a stabilising effect against 
haemolysis.  Even at the maximum prescribed dose a patient would have a 10 fold 
protective margin (0.5 mg/ml) before suffering any haemolytic effects, as 0.904 mg/ml 
caused <5 % haemolysis immediately after dosing at 100 % PBS (Fig. 4).  However, if 
the patient was in trauma with abnormally dilute blood osmolarity, an overdose could 
cause serious instantaneous effects; 70 mM NaCl 100 % haemolysis was caused by 
0.904 mg/ml imipramine.  Cardiovascular illness has been associated with imipramine 
Fig. 6.  Effect of varied imipramine doses over 60 min incubation at 100 % PBS.  Drug-
free control (●), 0.904 mg/ml (○), 9.04 mg/ml (▼), 18.08 mg/ml (∆) 27.12 mg/ml (■), 
36.16 mg/ml (□), 45.20 mg/ml (♦).  Cells were incubated for 5 min.  Data plots are means 
as a percentage of 100 % lysis control, n = 3.  27.12 mg/ml and higher were significantly 
different to the control (ANOVA, P = <0.05). 
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(Jefferson, 1975) leading to disturbance in osmoregulatory systems, even a few percent 
of hypo-osmotic stress could significantly increase haemolysis levels at high imipramine 
dose; at 112 mM NaCl 0.904 mg/ml caused >10 % haemolysis.  Progressive increase in 
imipramine-induced haemolysis over time (Fig. 6) indicates long term exposure to an 
overdose could have serious implications; 7 % haemolysis was caused after 60 min. 
 
4.2. Imipramine concentration dependent haemolysis 
The results show that high concentration of imipramine, 90.4 mg/ml caused complete 
haemolysis despite the osmotic environment.  Even a 10 fold reduction in 
concentrations of imipramine caused high levels of cell lysis, compared to controls.  
This indicates the drug either has a toxic effect on cell membrane stability or disrupts 
integral cell volume control mechanisms.  The interesting result of 0.0904 mg/ml 
imipramine causing less lysis than the control (Fig 3) may be explained by the surface 
action of the imipramine molecules.  Formation of liquid membranes by ampiphillic 
molecules may explain the inhibiting effect of imipramine on monoamine reuptake at 
synapses.  At concentrations significantly higher than CMC imipramine forms multiple 
surfactant layers at the interface of the synaptic terminal and the cleft, this extra 
membrane disrupts movements of permeants.  Hence neurotransmitters, like 
noradrenaline, cannot be absorbed into transport vesicles and remain in the synaptic 
cleft increasing noradrenergic action; this ultimately propagates a therapeutic effect 
since depression is associated with decreased noradrenergic action at the synapses.  
Liquid membranes can develop at the interface of any two liquids, since erythrocyte 
membranes closely resemble that of nerve cells (Rybakowski, 1990) imipramine 
molecules may form liquid membranes around the erythrocytes in solution with those 
cells. 
Since at and above CMC a complete liquid membrane is formed by the surfactant 
imipramine molecules, then below CMC only a partial liquid membrane may form, in 
keeping with the Kesting hypothesis.  A low concentration of imipramine, 0.0904 mg/ml, 
appears to have a stabilising lytic effect on RBCs under stress, lending credence to the 
effect of liquid membrane formation.  The CMC for imipramine is 1.48x10-4 M so 0.0904 
mg/ml or 2.8x10-4 M is very close to it, indicating that the molecules form a thin liquid 
membrane but cannot build up layers of surfactant to disrupt movements of permeants 
through aquaporins, ion exchangers and the bilayer.  The liquid membrane explains the 
stabilising effect of imipramine; the partial liquid membrane reinforces the erythrocyte 
membrane.  Cells placed in a hypotonic solution are under stress, the liquid membrane 
reduces the hydraulic conductivity co-efficient, allowing for greater viscoelasticity and 
greater resistance to stress induced haemolysis. 
Literature supports the stability theory; the ‘liquid membrane hypothesis of drug action’ 
developed as a result of many studies finding drugs interacting with membranes 
(Srivastava, 1981).  Some studies found that surface active drugs like neuroleptic drugs 
interact with and can exert a stabilising effect on membranes (Seeman & Bialy, 1963; 
Seeman, 1966) including erythrocyte membranes (Seeman & Weinstein, 1966).  A 
study by Srivistava et al. (1982) found specifically that imipramine in vitro formed a 
liquid membrane with a supporting membrane and reduced permeability to cations at 
concentrations above CMC.  Further support for imipramine showing a stabilising effect 
on lysis of cells under stress comes from Yashura et al. (1980).  This current study 
found that at 2.8x10-4 M (0.0904mg/ml) imipramine protected against hypotonic 
haemolysis but above this it facilitated haemolysis. Yashura et al. (1980) found that 
imipramine protected rat erythrocytes from hypotonic haemolysis at concentrations from 
1x10-5 M to 4x10-4 M but facilitated haemolysis at concentrations above 4x10-4 M.  
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Similarly support from the literature is found in a study investigating the effect of 
neuroleptic drugs on cell membranes and lithium transport in erythrocytes (Azizabadi-
Farahani et al., 1996).  Recently Nagappa et al. (2003) found that imipramine at 
concentrations of 2x10-4 M, above CMC, forms a liquid membrane in series with a 
supporting membrane significantly reducing the transport of adrenaline.  As with this 
study, they also found a proportional decrease in hydraulic conductivity co-efficient as 
drug concentration increased towards CMC.  Hence a drug concentration close to CMC 
should show less sensitivity when submitted to a hydraulic gradient than concentrations 
significantly higher than CMC, borne out in this study as 0.0904 mg/ml or 3.2x10-4 M is 
close to the imipramine CMC of 1.48x10-4 M (Srivastava et al., 1982).  The results show 
that higher concentrations of imipramine did not reduce sensitivity to water permeability; 
instead haemolysis was facilitated by the drug, also in keeping with Nagappa et al. 
(2003) who found that higher concentrations of imipramine significantly above CMC had 
a relatively consistent hydraulic conductivity co-efficient.  The conclusions in this study 
and in Nagappa et al. (2003) match those of Srivistava (1982) all of which show that as 
imipramine concentrations build to CMC there is a decrease in hydraulic conductivity 
co-efficient, which supports Kesting’s liquid membrane hypothesis.  Imipramine 
molecules at concentrations much higher than 1.48x10-4 M form a multilayer liquid 
membrane over erythrocyte membranes, which facilitate lysis by reducing transport of 
permeants such as cations involved in RVD mechanisms.  At concentrations around 
1.48x10-4 M imipramine molecules progressively form a liquid membrane over the 
surface of the erythrocyte reducing the hydraulic conductivity co-efficient and so 
stabilising the cell against lysis. 
Liquid membrane formation is not the only possible explanation for the concentration 
dependent haemolytic effect of imipramine.  It has been established that the ampiphillic 
nature of the imipramine molecule interferes with pumps on the erythrocyte membrane, 
if Ca2+ movement out of the cell is interfered with high intracellular Ca2+ levels could 
compromise the membrane integrity and cause lysis.  Ca2+ pump plays a role in RVD 
mechanisms; if impramine interferes with the pump the cell cannot adjust to prevent 
lysis in a hypo-osmotic environment, therefore haemolysis levels would increase with 
imipramine concentration.  In the same way the results may be explained by the fact 
that imipramine interferes with Na+K+ pumps on the erythrocyte membrane, as 
imipramine concentration increases the damaging effect on cell volume control is 
intensified and haemolysis results.  The cumulative effect of imipramine on various 
membrane ion exchangers could explain the increase in imipramine-induced 
haemolysis over time. 
An alternative explanation for the results is found in Ahyayauch et al. (2004).  In these 
experiments pH was not carefully controlled, Ahyayauch et al. (2004) showed data 
supporting these results, with imipramine causing destabilising effects to erythrocyte 
membranes, but they also found that pH affected the interaction with the membrane due 
to changes in the charge of the ampiphile.  Imipramine molecules were found to interact 
more strongly and have the greatest protective effect against hypotonic haemolysis at 
close to neutral pH (Ahyayauch et al., 2004).  Therefore the stabilising effects seen here 
at 0.0904 mg/ml may be a result of the neutral pH of the solution increasing adsorption 
to the membrane while higher concentrations caused a change in pH, reducing 
adsorption to the membrane.  Further research could investigate changes in pH as a 
result of increasing imipramine HCL concentration. 
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4.3. Incubation-time dependent haemolysis 
The results for the time trials may be explained by imipramine molecules interfering with 
ion pumps disrupting cell volume control mechanisms.  Liquid membrane formation may 
be the explanation for this disruption at the cell surface.  Around the CMC at 
0.0904mg/ml the membrane is stabilised and a lower percentage haemolysis is caused 
than when there is no drug present to stabilise the membrane by forming a liquid 
membrane.  The higher concentrations of drug indicate increasing percentage 
haemolysis over time as a result of longer exposure to the drug forming multilayered 
liquid membranes over the cells.  The time trials were carried out at 100 % PBS, 
approximately physiological saline, so cell volume control mechanisms were not 
activated, but over the incubation time the interference of the imipramine molecules with 
the movement of permeants and cations compromises the intracellular mechanisms 
leading to disruption and necrotic cell death – haemolysis.  Nagappa et al. (2003) 
support this theory, that high concentrations of imipramine disrupted the movement of 
cations and biogenic amines.  The influence of the orientation of the ampiphillic 
molecules in liquid membranes and how this affects the permeability of ions was 
investigated in the Srivistava (1982) study.  They found that both orientation of 
molecules and hydrophilicity of ions reduced permeability to cations. 
 
5. Conclusion 
The results and the relevant literature indicate with robust support that imipramine does 
have an effect on erythrocyte haemolysis.  Liquid membranes are intrinsic to both 
imipramine mechanism of inhibiting movement of biogenic amines at high 
concentrations, and to the membrane stabilising effect at low concentrations.  Overall it 
is important to note that the surface activity of imipramine influences its mechanism and 
can have implications for research involving ion exchange and flux at cell membranes.  
Conclusions regarding surface activity of imipramine on erythrocytes and support from 
other studies help understand imipramine mechanism and the effects the molecule has 
on nerve conduction.  Temperature was not closely controlled in either time trials or 
dosage experiments, and was approximately room temperature; 20oC, further research 
should investigate the effects of liquid membrane formation with the cells under 
temperature stress, and the effect of pH on imipramine-induced haemolysis. 
Further research needs to look specifically at the effects of liquid membranes on both 
passive and active transport across cell membranes to investigate imipramine effect on 
nerve conduction.  This study should be repeated looking at concentrations of 
imipramine HCL far below its CMC to investigate the effects on lysis as concentration 
rises to CMC.  Further investigation may support the theory that progressive formation 
of liquid membranes by surface active drugs can exert a stabilising effect on 
membranes, and would verify findings from other studies on the liquid membrane 
hypothesis. 
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